全文获取类型
收费全文 | 7412篇 |
免费 | 428篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 289篇 |
妇产科学 | 163篇 |
基础医学 | 697篇 |
口腔科学 | 178篇 |
临床医学 | 555篇 |
内科学 | 1667篇 |
皮肤病学 | 174篇 |
神经病学 | 503篇 |
特种医学 | 185篇 |
外科学 | 1604篇 |
综合类 | 125篇 |
一般理论 | 2篇 |
预防医学 | 269篇 |
眼科学 | 195篇 |
药学 | 621篇 |
中国医学 | 34篇 |
肿瘤学 | 530篇 |
出版年
2023年 | 68篇 |
2022年 | 47篇 |
2021年 | 325篇 |
2020年 | 206篇 |
2019年 | 260篇 |
2018年 | 360篇 |
2017年 | 235篇 |
2016年 | 285篇 |
2015年 | 258篇 |
2014年 | 412篇 |
2013年 | 455篇 |
2012年 | 744篇 |
2011年 | 699篇 |
2010年 | 397篇 |
2009年 | 359篇 |
2008年 | 419篇 |
2007年 | 452篇 |
2006年 | 384篇 |
2005年 | 327篇 |
2004年 | 240篇 |
2003年 | 187篇 |
2002年 | 143篇 |
2001年 | 37篇 |
2000年 | 42篇 |
1999年 | 35篇 |
1998年 | 24篇 |
1997年 | 22篇 |
1996年 | 19篇 |
1995年 | 18篇 |
1994年 | 13篇 |
1993年 | 16篇 |
1992年 | 43篇 |
1991年 | 41篇 |
1990年 | 22篇 |
1989年 | 26篇 |
1988年 | 21篇 |
1987年 | 27篇 |
1986年 | 20篇 |
1985年 | 24篇 |
1984年 | 13篇 |
1983年 | 11篇 |
1981年 | 9篇 |
1980年 | 5篇 |
1979年 | 11篇 |
1978年 | 6篇 |
1977年 | 11篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1973年 | 5篇 |
排序方式: 共有7873条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Michael T Milano Veronica L S Chiang Scott G Soltys Tony J C Wang Simon S Lo Alexandria Brackett Seema Nagpal Samuel Chao Amit K Garg Siavash Jabbari Lia M Halasz Melanie Hayden Gephart Jonathan P S Knisely Arjun Sahgal Eric L Chang 《Neuro-oncology》2020,22(12):1728
BackgroundThe American Radium Society (ARS) Appropriate Use Criteria brain malignancies panel systematically reviewed (PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses]) published literature on neurocognitive outcomes after stereotactic radiosurgery (SRS) for patients with multiple brain metastases (BM) to generate consensus guidelines.MethodsThe panel developed 4 key questions (KQs) to guide systematic review. From 11 614 original articles, 12 were selected. The panel developed model cases addressing KQs and potentially controversial scenarios not addressed in the systematic review (which might inform future ARS projects). Based upon quality of evidence, the panel confidentially voted on treatment options using a 9-point scale of appropriateness.ResultsThe panel agreed that SRS alone is usually appropriate for those with good performance status and 2–10 asymptomatic BM, and usually not appropriate for >20 BM. For 11–15 and 16–20 BM there was (between 2 case variants) agreement that SRS alone may be appropriate or disagreement on the appropriateness of SRS alone. There was no scenario (among 6 case variants) in which conventional whole-brain radiotherapy (WBRT) was considered usually appropriate by most panelists. There were several areas of disagreement, including: hippocampal sparing WBRT for 2–4 asymptomatic BM; WBRT for resected BM amenable to SRS; fractionated versus single-fraction SRS for resected BM, larger targets, and/or brainstem metastases; optimal treatment (WBRT, hippocampal sparing WBRT, SRS alone to all or select lesions) for patients with progressive extracranial disease, poor performance status, and no systemic options.ConclusionsFor patients with 2–10 BM, SRS alone is an appropriate treatment option for well-selected patients with good performance status. Future study is needed for those scenarios in which there was disagreement among panelists. 相似文献
5.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
6.
7.
8.
9.
10.